Công Ty Cổ Phần JW Euvipharm

JW Euvipharm, acquired by Korean top pharmaceutical company JW Group in 2019, aims to penetrate the Vietnamese and global pharmaceutical markets. With advanced GMP standards and a commitment to producing high-quality pharmaceuticals, JW Euvipharm strives to contribute to the health of the Vietnamese population and humanity as a whole. We operate by granting distribution rights to distributors and other pharmaceutical companies rather than directly bidding or selling to hospitals or pharmacies.